Kind Patches Review: Do the GLP-1 / Berberine Patches Work? (2026)

Kind Patches was running 61 Facebook/Instagram ads at once in July 2026 and its “$29 GLP-1 patch” creative is on major news sites. Here's the independent, sourced review — including the class action the ads don't mention.

Who's behind Kind Patches

The seller is Kind Patches Limited, a UK private company (Companies House no. 15263256) incorporated on 6 November 2023 — so it has been trading for roughly 20 months as of this review. Its own “Who We Are” page names no founders, location or founding date. The product is sold direct-to-consumer and via Amazon and Bloomingdale's; we found no evidence it's sold at Costco, despite the ad wording.

What's actually in the patch

Per the brand's own product page and the class-action complaint, each patch contains a berberine blend (berberine, pomegranate and cinnamon extracts), L-glutamine, and a ~3.5 mg vitamin-B complex (B1, B2, B3, B6, B9, B12). There is no semaglutide, tirzepatide, or any GLP-1 receptor agonist in it — which there legally couldn't be in an over-the-counter product. Berberine is a real compound with modest metabolic effects in studies, but those used 900–1,500 mg swallowed daily; a patch delivers a few milligrams to the skin surface. See our category explainer on why a patch can't deliver a GLP-1 drug.

The marketing claims vs. the evidence

The sales page advertises figures like “reduced food intake by 47.5%,” “92.3% reported fewer cravings,” and “82.3% cut back on snacking,” alongside the standard “these statements have not been evaluated by the FDA” disclaimer. Those percentages are presented as the product's own marketing, not as results from a published, peer-reviewed trial of the patch. The core implied promise — Ozempic-style appetite suppression from a stick-on patch — isn't supported by any evidence we could find, and runs into the basic pharmacology problem that GLP-1 molecules are far too large to cross intact skin.

The class action (October 2025)

On October 31, 2025, Kind Patches Limited was named in a class action (Alaimo v. Kind Patches Limited) filed in New York under the state's General Business Law. Per the complaint summary, the suit alleges the company falsely marketed the patches as effective, Ozempic-comparable weight-loss products despite containing no GLP-1 agonist; that it instructed influencers to film themselves holding an Ozempic pen next to the patch to imply equivalence; and that it later rebranded the product to “Berberine Patch” while keeping the same messaging. These are allegations; as of this writing we're not aware of a court ruling on the merits, and the company is entitled to defend the claims.

Cost, subscription and cancellation

Pricing on the brand's page: $12.75/month on a 30-patch subscription (billed as 15% off the $15 list), $15 for a one-time single pack, or a buy-2-get-1-free bundle at $30. We did not see a clear money-back guarantee on the main landing page. As with most auto-ship supplement offers, read the recurring-billing and cancellation terms before ordering — subscription friction is a common complaint pattern across this category.

Red flags we found

• Markets a berberine-and-vitamin patch with GLP-1 / Ozempic framing while containing no GLP-1 drug.
• Named in an October 2025 New York class action alleging deceptive Ozempic-comparison marketing (allegations, not yet adjudicated).
• Product quietly renamed “Berberine Patch” while the GLP-1 marketing continued, per the complaint.
• Ad implies Costco availability and mass adoption (“taking the US by storm”) with no verifiable basis; no clear money-back guarantee on the landing page.

What to do instead — the legitimate paths

This is the part the ads skip: the real, verified ways to make an actual GLP-1 affordable.

Sources

1. Alaimo v. Kind Patches Limited — class-action summary (filed Oct 31, 2025, NY GBL) — https://www.classaction.org/news/kind-patches-lawsuit-alleges-patches-cannot-meaningfully-increase-natural-glp-1-levels-as-advertised · accessed July 13, 2026
2. Kind Patches — product & pricing page — https://kindpatches.com/pages/glplpv5 · accessed July 13, 2026
3. UK Companies House — Kind Patches Limited (15263256) — https://find-and-update.company-information.service.gov.uk/company/15263256 · accessed July 13, 2026
4. Rolling Stone — GLP-1 patch influencer marketing investigation — https://www.rollingstone.com/culture/culture-features/glp1-patches-influencers-ozempic-1235403902/ · accessed July 13, 2026
5. Drugs.com — Do GLP-1 patches work? FDA approval & evidence — https://www.drugs.com/medical-answers/glp-1-patches-work-fda-approval-proven-benefit-3582314/ · accessed July 13, 2026

Independence: we have no affiliate or business relationship with any product reviewed on this page and accept nothing from the brands. If a clearly-labeled partner option ever appears in the "legitimate paths" section, it never changes the verdict or which lowest-cost path we show first.